这是一篇来自已证抗体库的有关人类 TNFR2的综述,是根据18篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合TNFR2 抗体。
TNFR2 同义词: CD120b; TBPII; TNF-R-II; TNF-R75; TNFBR; TNFR1B; TNFR2; TNFR80; p75; p75TNFR

艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR1653)
  • 免疫印迹; 人类; 1:1000; 图 2f
艾博抗(上海)贸易有限公司 TNFR2抗体(Abcam, ab109322)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2f). Front Cell Dev Biol (2021) ncbi
domestic rabbit 单克隆(EPR1653)
  • 免疫组化; 人类; 图 1d
艾博抗(上海)贸易有限公司 TNFR2抗体(Abcam, ab109322)被用于被用于免疫组化在人类样本上 (图 1d). Exp Ther Med (2021) ncbi
domestic rabbit 单克隆(EPR1653)
  • 免疫组化; 小鼠; 图 3e
艾博抗(上海)贸易有限公司 TNFR2抗体(Abcam, ab109322)被用于被用于免疫组化在小鼠样本上 (图 3e). FEBS Open Bio (2020) ncbi
domestic rabbit 单克隆(EPR1653)
  • 免疫印迹; 小鼠; 1:1000; 图 1a
艾博抗(上海)贸易有限公司 TNFR2抗体(Abcam, ab109322)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Mol Metab (2020) ncbi
domestic rabbit 单克隆(EPR1653)
  • 流式细胞仪; 人类; 图 s4a
艾博抗(上海)贸易有限公司 TNFR2抗体(Abcam, ab109322)被用于被用于流式细胞仪在人类样本上 (图 s4a). Mol Cancer Res (2019) ncbi
domestic rabbit 单克隆
  • 免疫印迹; 小鼠; 图 1e
艾博抗(上海)贸易有限公司 TNFR2抗体(Abcam, ab221921)被用于被用于免疫印迹在小鼠样本上 (图 1e). J Immunol (2018) ncbi
domestic rabbit 单克隆(EPR1653)
  • 免疫细胞化学; 人类; 1:250; 图 4b
艾博抗(上海)贸易有限公司 TNFR2抗体(Abcam, EPR1653)被用于被用于免疫细胞化学在人类样本上浓度为1:250 (图 4b). J Exp Med (2016) ncbi
安迪生物R&D
仓鼠 单克隆(TR7554)
  • 免疫组化; 小鼠; 图 2, 5b, 6
安迪生物R&D TNFR2抗体(R&D Systems, FAB426A)被用于被用于免疫组化在小鼠样本上 (图 2, 5b, 6). JCI Insight (2019) ncbi
圣克鲁斯生物技术
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 TNFR2抗体(Santa Cruz, sc-8041)被用于被用于免疫印迹在人类样本上 (图 1). Int J Mol Med (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 TNFR2抗体(Santa Cruz Biotechnology, sc-8041)被用于被用于免疫印迹在人类样本上. Carcinogenesis (2009) ncbi
赛默飞世尔
小鼠 单克隆(MR2-1)
  • 流式细胞仪; 人类; 图 s1a
赛默飞世尔 TNFR2抗体(Invitrogen, MR2.1)被用于被用于流式细胞仪在人类样本上 (图 s1a). Front Immunol (2016) ncbi
小鼠 单克隆(897C2G9)
  • 酶联免疫吸附测定; 人类; 1 ug/ml; 图 4
赛默飞世尔 TNFR2抗体(Biosource, clone 897C2G9)被用于被用于酶联免疫吸附测定在人类样本上浓度为1 ug/ml (图 4). Gastroenterology (2002) ncbi
BioLegend
大鼠 单克隆(3G7A02)
  • 流式细胞仪; 人类; 图 4
BioLegend TNFR2抗体(Biolegend, 3G7A02)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2016) ncbi
上海普洛麦格生物产品有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1a
  • 免疫印迹基因敲除验证; 小鼠; 图 4a
上海普洛麦格生物产品有限公司 TNFR2抗体(Promega, G3231)被用于被用于免疫印迹在人类样本上 (图 1a) 和 被用于免疫印迹基因敲除验证在小鼠样本上 (图 4a). Front Pharmacol (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200; 图 2d
上海普洛麦格生物产品有限公司 TNFR2抗体(Promega, G3231)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 2d). Dev Biol (2016) ncbi
碧迪BD
大鼠 单克隆(hTNFR-M1)
  • 流式细胞仪; 人类; 表 3
碧迪BD TNFR2抗体(BD Pharmingen, hTNFR-M1)被用于被用于流式细胞仪在人类样本上 (表 3). Brain Behav (2016) ncbi
大鼠 单克隆(hTNFR-M1)
  • 流式细胞仪; 人类; 图 st1
碧迪BD TNFR2抗体(BD, 552418)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
大鼠 单克隆(hTNFR-M1)
  • 流式细胞仪; 人类
碧迪BD TNFR2抗体(BD Bioscience, hTNFR-M1)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
文章列表
  1. Liu W, Brodsky A, Feng M, Liu Y, Ding J, Jayasuriya C, et al. Senescent Tissue-Resident Mesenchymal Stromal Cells Are an Internal Source of Inflammation in Human Osteoarthritic Cartilage. Front Cell Dev Biol. 2021;9:725071 pubmed 出版商
  2. Li Q, Cheng F, Zhou K, Fang L, Wu J, Xia Q, et al. Increased sensitivity to TNF-α promotes keloid fibroblast hyperproliferation by activating the NF-κB, JNK and p38 MAPK pathways. Exp Ther Med. 2021;21:502 pubmed 出版商
  3. Li Z, Murakoshi M, Ichikawa S, Koshida T, Adachi E, Suzuki C, et al. The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice. FEBS Open Bio. 2020;10:2761-2770 pubmed 出版商
  4. Xu M, Ge C, Qin Y, Lou D, Li Q, Feng J, et al. Functional loss of inactive rhomboid-like protein 2 mitigates obesity by suppressing pro-inflammatory macrophage activation-triggered adipose inflammation. Mol Metab. 2020;34:112-123 pubmed 出版商
  5. Raphael I, Gomez Rivera F, Raphael R, Robinson R, Nalawade S, Forsthuber T. TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019;4: pubmed 出版商
  6. Vickman R, Yang J, Lanman N, Cresswell G, Zheng F, Zhang C, et al. Cholesterol Sulfotransferase SULT2B1b Modulates Sensitivity to Death Receptor Ligand TNFα in Castration-Resistant Prostate Cancer. Mol Cancer Res. 2019;17:1253-1263 pubmed 出版商
  7. Cabron A, El Azzouzi K, Boss M, Arnold P, Schwarz J, Rosas M, et al. Structural and Functional Analyses of the Shedding Protease ADAM17 in HoxB8-Immortalized Macrophages and Dendritic-like Cells. J Immunol. 2018;201:3106-3118 pubmed 出版商
  8. Pediaditakis I, Kourgiantaki A, Prousis K, Potamitis C, Xanthopoulos K, Zervou M, et al. BNN27, a 17-Spiroepoxy Steroid Derivative, Interacts With and Activates p75 Neurotrophin Receptor, Rescuing Cerebellar Granule Neurons from Apoptosis. Front Pharmacol. 2016;7:512 pubmed 出版商
  9. Ma W, Tummers B, van Esch E, Goedemans R, Melief C, Meyers C, et al. Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFN?- and TNF?-Mediated Antiproliferative Effects and Necroptosis. Front Immunol. 2016;7:496 pubmed
  10. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  11. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed 出版商
  12. Wu S, Kanda T, Nakamoto S, Jiang X, Nakamura M, Sasaki R, et al. Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-?B. Int J Mol Med. 2016;38:475-81 pubmed 出版商
  13. Lee Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, et al. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol. 2016;196:3385-97 pubmed 出版商
  14. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  15. Chandler R, Magnuson T. The SWI/SNF BAF-A complex is essential for neural crest development. Dev Biol. 2016;411:15-24 pubmed 出版商
  16. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed 出版商
  17. Luce A, Courtin A, Levalois C, Altmeyer Morel S, Romeo P, Chevillard S, et al. Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells. Carcinogenesis. 2009;30:432-9 pubmed 出版商
  18. Mizoguchi E, Mizoguchi A, Takedatsu H, Cario E, De Jong Y, Ooi C, et al. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology. 2002;122:134-44 pubmed